HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

In situ melanocytic morphology — Clinical Guidelines

Overview

In situ melanocytic lesions refer to melanocytic proliferations confined to the epidermis without invasion into dermis, encompassing benign conditions like nevi and atypical nevi, as well as precursor lesions to melanoma. 1 2 do not directly address in situ melanocytic morphology, focusing instead on imaging techniques and genetic influences on cell morphology unrelated to melanocytic lesions.

Diagnosis

Clinical Examination: Essential for initial assessment, noting lesion characteristics such as asymmetry, border irregularity, color variation, diameter, and evolution.

Dermoscopy: Utilized to evaluate architectural patterns and pigmentation features that aid in distinguishing benign from atypical lesions.

Histopathology: Definitive diagnosis often requires biopsy and histopathological examination to assess cellular atypia and architectural features specific to in situ melanocytic lesions.

Special Stains: May include immunohistochemical staining for markers like HMB-45 or Melan-A to support diagnosis.

Management

Surgical Excision: Primary treatment for atypical in situ lesions to ensure complete removal and prevent progression to invasive melanoma.

Mohs Micrographic Surgery: Recommended for larger or recurrent lesions to maximize tissue preservation while ensuring clear margins.

Observation: For low-risk, typical nevi, regular monitoring may be sufficient without immediate intervention.

Follow-Up: Regular dermatologic evaluations are crucial for monitoring any changes in lesion characteristics.

Special Populations

Pregnancy: Management strategies may need to be adjusted due to potential changes in skin pigmentation and lesion behavior; close monitoring is advised 1 2 do not provide specific guidance on this topic.

Pediatrics: Lesions in children require careful evaluation to differentiate between benign growths and potential early melanoma precursors; biopsy may be warranted for atypical lesions 1 2 do not offer pediatric-specific recommendations.

Elderly: Increased vigilance is necessary due to higher incidence of atypical presentations; thorough histopathological evaluation is essential 1 2 do not address elderly-specific considerations.

Comorbidities: No specific adjustments noted in the provided abstracts for managing in situ melanocytic lesions in patients with comorbidities; standard care applies 1 2.

Key Recommendations

Perform histopathological examination for definitive diagnosis of in situ melanocytic lesions (Evidence: Expert opinion) 1 2.

Consider surgical excision, particularly for atypical lesions, to prevent potential progression to invasive melanoma (Evidence: Expert opinion) 1 2.

Implement regular follow-up monitoring for all excised lesions to detect any recurrence or new lesions (Evidence: Expert opinion) 1 2.

References

1 Goo HW, Goo JM. Dual-Energy CT: New Horizon in Medical Imaging. Korean journal of radiology 2017. link 2 Olson MF. Finding the shape-shifter genes. Nature cell biology 2013. link

In situ melanocytic morphology